The World Health Organization had published earlier this year a list of the most concerning pathogens. The WHO continues with a report on the pipeline of antibiotics currently in clinical development to assess how we are going to manage the pathogens of the list.
The conclusions are that the pipeline contains too few new drugs able to combat antimicrobial resistance. Most of the drugs in development are modificatoins of already existing classes.
Strong efforts are needed to reinforce the pipeline.